NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Real-life Study on the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma

NCT07777406

RecruitingN/A

Sponsor: Università degli Studi 'G. d'Annunzio' Chieti e Pescara

Conditions: Plasma Cell Neoplasms

Countries: Italy

A multicenter, non-interventional, observational, retrospective and prospective pharmacological study aimed at evaluating the use of allogeneic hematopoietic stem cell transplantation in patients with relapsed/refractory multiple myeloma.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* patients diagnosed with relapsed/refractory multiple myeloma according to IMWG criteria who have undergone allogeneic hematopoietic stem cell transplantation;
* Age ≥ 18 years;
* Signature of the informed consent form (where possible).

Exclusion Criteria:

* Patients diagnosed with primary AL amyloidosis, monoclonal gammopathy of undetermined significance (MGUS), indolent multiple myeloma, or primary plasma cell leukemia;
* Patients who have not undergone allogeneic hematopoietic stem cell transplantation;
* Age \< 18 years.

Locations (1)

Chieti, CH, Italy